Ligand Pharmaceuticals Inc (LGND): David M. Knott of Dorset Management Resigned from the Board

Page 3 of 5 – SEC Filing

 

CUSIP No. 53220K504						13D
	1	Name of Reporting Persons. I.R.S. Identification Nos. of Above Persons (Entities Only) Dorset Management Corporation 11-2873658
	2	Check the Appropriate Box if a Member of a Group.(See Instructions)
		(a)			o
		(b)			x
	3	SEC Use Only
	4	Source of Funds (See Instructions) WC
	5	Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e)     o
	6	Citizenship or Place of Organization New York
Number of Shares Beneficially Owned by Each Reporting Person With			7	Sole Voting Power 1,196,257 shares of Common Stock
			8	Shared Voting Power 1,666 shares of Common Stock
			9	Sole Dispositive Power 1,197,923 shares of Common Stock
			10	Shared Dispositive Power 0 shares of Common Stock
	11	Aggregate Amount Beneficially Owned by Each Reporting Person 1,197,923 shares of Common Stock
	12	Check Box if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions)   o
	13	Percent of Class Represented by Amount in Row (11) 5.8%
	14	Type of Reporting Person (See Instructions) CO

 

3

---